These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, Gayle RB, Maliszewski CR. J Clin Invest; 1997 Mar 15; 99(6):1351-60. PubMed ID: 9077545 [Abstract] [Full Text] [Related]
3. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism. Kaneider NC, Egger P, Dunzendorfer S, Noris P, Balduini CL, Gritti D, Ricevuti G, Wiedermann CJ. Arterioscler Thromb Vasc Biol; 2002 Jun 01; 22(6):894-900. PubMed ID: 12067895 [Abstract] [Full Text] [Related]
4. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Guckelberger O, Sun XF, Sévigny J, Imai M, Kaczmarek E, Enjyoji K, Kruskal JB, Robson SC. Thromb Haemost; 2004 Mar 01; 91(3):576-86. PubMed ID: 14983235 [Abstract] [Full Text] [Related]
5. Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes. Koziak K, Sévigny J, Robson SC, Siegel JB, Kaczmarek E. Thromb Haemost; 1999 Nov 01; 82(5):1538-44. PubMed ID: 10595651 [Abstract] [Full Text] [Related]
6. CD39 modulates endothelial cell activation and apoptosis. Goepfert C, Imai M, Brouard S, Csizmadia E, Kaczmarek E, Robson SC. Mol Med; 2000 Jul 01; 6(7):591-603. PubMed ID: 10997340 [Abstract] [Full Text] [Related]
7. Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae. Koziak K, Kaczmarek E, Kittel A, Sévigny J, Blusztajn JK, Schulte Am Esch J, Imai M, Guckelberger O, Goepfert C, Qawi I, Robson SC. J Biol Chem; 2000 Jan 21; 275(3):2057-62. PubMed ID: 10636909 [Abstract] [Full Text] [Related]
8. Role of extracellular ATP metabolism in regulation of platelet reactivity. Birk AV, Broekman MJ, Gladek EM, Robertson HD, Drosopoulos JH, Marcus AJ, Szeto HH. J Lab Clin Med; 2002 Sep 21; 140(3):166-75. PubMed ID: 12271274 [Abstract] [Full Text] [Related]
9. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice. Covarrubias R, Chepurko E, Reynolds A, Huttinger ZM, Huttinger R, Stanfill K, Wheeler DG, Novitskaya T, Robson SC, Dwyer KM, Cowan PJ, Gumina RJ. Arterioscler Thromb Vasc Biol; 2016 Sep 21; 36(9):1809-20. PubMed ID: 27417582 [Abstract] [Full Text] [Related]
10. Transmembrane domains confer different substrate specificities and adenosine diphosphate hydrolysis mechanisms on CD39, CD39L1, and chimeras. Grinthal A, Guidotti G. Biochemistry; 2002 Feb 12; 41(6):1947-56. PubMed ID: 11827541 [Abstract] [Full Text] [Related]
11. Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas. Dzhandzhugazyan KN, Kirkin AF, thor Straten P, Zeuthen J. FEBS Lett; 1998 Jul 03; 430(3):227-30. PubMed ID: 9688544 [Abstract] [Full Text] [Related]
12. Perindopril augments ecto-ATP diphosphohydrolase activity and enhances endothelial anti-platelet function in human umbilical vein endothelial cells. Kishi Y, Ohta S, Kasuya N, Sakita SY, Ashikaga T, Isobe M. J Hypertens; 2003 Jul 03; 21(7):1347-53. PubMed ID: 12817183 [Abstract] [Full Text] [Related]
13. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Schulte am Esch J, Sévigny J, Kaczmarek E, Siegel JB, Imai M, Koziak K, Beaudoin AR, Robson SC. Biochemistry; 1999 Feb 23; 38(8):2248-58. PubMed ID: 10029517 [Abstract] [Full Text] [Related]
14. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Marcus AJ, Broekman MJ, Drosopoulos JH, Olson KE, Islam N, Pinsky DJ, Levi R. Semin Thromb Hemost; 2005 Apr 23; 31(2):234-46. PubMed ID: 15852226 [Abstract] [Full Text] [Related]
15. Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases1. Smith TM, Kirley TL. Biochim Biophys Acta; 1998 Jul 28; 1386(1):65-78. PubMed ID: 9675246 [Abstract] [Full Text] [Related]
16. Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39. Neshat S, deVries M, Barajas-Espinosa AR, Skeith L, Chisholm SP, Lomax AE. Am J Physiol Gastrointest Liver Physiol; 2009 Feb 28; 296(2):G399-405. PubMed ID: 19074640 [Abstract] [Full Text] [Related]
17. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. Gayle RB, Maliszewski CR, Gimpel SD, Schoenborn MA, Caspary RG, Richards C, Brasel K, Price V, Drosopoulos JH, Islam N, Alyonycheva TN, Broekman MJ, Marcus AJ. J Clin Invest; 1998 May 01; 101(9):1851-9. PubMed ID: 9576748 [Abstract] [Full Text] [Related]
18. Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Leal DB, Streher CA, Neu TN, Bittencourt FP, Leal CA, da Silva JE, Morsch VM, Schetinger MR. Biochim Biophys Acta; 2005 Jan 18; 1721(1-3):9-15. PubMed ID: 15652174 [Abstract] [Full Text] [Related]
19. Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5'-nucleotidase in myeloid leukocytes. Clifford EE, Martin KA, Dalal P, Thomas R, Dubyak GR. Am J Physiol; 1997 Sep 18; 273(3 Pt 1):C973-87. PubMed ID: 9316419 [Abstract] [Full Text] [Related]
20. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. Imai M, Takigami K, Guckelberger O, Enjyoji K, Smith RN, Lin Y, Csizmadia E, Sévigny J, Rosenberg RD, Bach FH, Robson SC. Mol Med; 1999 Nov 18; 5(11):743-52. PubMed ID: 10656876 [Abstract] [Full Text] [Related] Page: [Next] [New Search]